NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 71266-6641-01 — Sodium citrate 4% solutionAI (121 hospitals, 44,108–44,999 samples)
• NDC 69374-0949-05 — Lidocaine 2% numbing injection syringeAI (206 hospitals, 44,108–44,999 samples)
• NDC 69374-0924-05 — Rocuronium 50 mg/5 mL intravenous syringeAI (205 hospitals, 44,107–44,989 samples)
• NDC 51552-0051-06 — Acetic acid 3% solutionAI (416 hospitals, 44,319–44,940 samples)
• NDC 80830-2329-01 — Tranexamic acid IV infusion in salineAI (434 hospitals, 43,584–44,907 samples)
• NDC 00065-0303-55 — Atropine 1% eye dropsAI (238 hospitals, 43,801–44,890 samples)
• NDC 65219-0383-70 — Low-osmolar iodinated contrast dye, per mLAI (39 hospitals, 44,132–44,816 samples)
• NDC 47781-0601-91 — Tranexamic acid 1,000 mg IV solutionAI (148 hospitals, 43,771–44,698 samples)
• NDC 17478-0713-10 — OFLOXACIN 0.3 % EYE DROPSAI (337 hospitals, 43,564–44,671 samples)
• NDC 00006-5425-15 — Sugammadex injection to reverse anesthesia muscle relaxantAI (441 hospitals, 42,168–44,661 samples)
• NDC 71351-0021-05 — Lidocaine (1%) numbing injection solutionAI (201 hospitals, 41,007–44,643 samples)
• NDC 71266-2001-02 — Succinylcholine chloride injection, 200 mg per 10 mL syringeAI (343 hospitals, 43,315–44,494 samples)
• NDC 44567-0120-25 — Cefazolin sodium 1 g injectionAI (107 hospitals, 44,029–44,488 samples)
• NDC 70860-0777-20 — Ondansetron 2 mg/mL IV solutionAI (186 hospitals, 42,744–44,481 samples)
• NDC 68462-0157-13 — Ondansetron 4 mg dissolving tabletsAI (757 hospitals, 38,616–44,322 samples)
• NDC 63323-0563-10 — Tranexamic acid 1,000 mg IV solutionAI (169 hospitals, 43,162–44,197 samples)
• NDC 47781-0601-22 — Tranexamic acid intravenous solutionAI (97 hospitals, 43,288–44,170 samples)
• NDC 70069-0421-01 — Latanoprost eye drops 0.005%AI (613 hospitals, 42,971–44,168 samples)
• NDC 70860-0400-41 — Tranexamic acid 1,000 mg intravenous solutionAI (171 hospitals, 43,282–44,164 samples)
• NDC 67850-0042-10 — Tranexamic acid 1,000 mg/10 mL intravenous solutionAI (90 hospitals, 43,192–44,146 samples)
• NDC 70860-0400-10 — Tranexamic acid intravenous solutionAI (239 hospitals, 43,259–44,114 samples)
• NDC 67850-0042-00 — Tranexamic acid nebulizer solution made from IV solutionAI (71 hospitals, 43,186–44,086 samples)
• NDC 17478-0100-02 — CYCLOPENTOLATE 1 % EYE DROPSAI (334 hospitals, 42,937–44,017 samples)
• NDC 00013-1114-01 — Tranexamic acid 1,000 mg intravenous solutionAI (184 hospitals, 43,171–44,017 samples)
• NDC 63323-0806-13 — Fentanyl citrate (preservative-free) injection, 250 mcg/5 mLAI (306 hospitals, 36,563–43,997 samples)
• NDC 42571-0313-87 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (106 hospitals, 43,177–43,996 samples)
• NDC 67457-0163-02 — Sodium tetradecyl sulfate 3% injection, 2 mL vialAI (749 hospitals, 42,455–43,994 samples)
• NDC 69374-0901-05 — Ephedrine sulfate in saline syringeAI (160 hospitals, 42,983–43,973 samples)
• NDC 00990-7075-26 — Potassium chloride IV solutionAI (566 hospitals, 42,502–43,969 samples)
• NDC 00409-1283-03 — Hydromorphone injection, 1 mg/mLAI (559 hospitals, 38,658–43,959 samples)
• NDC 00409-1160-01 — Bupivacaine 0.25% injection solutionAI (464 hospitals, 38,088–43,929 samples)
• NDC 70756-0614-30 — Phenylephrine 10% eye dropsAI (604 hospitals, 42,750–43,857 samples)
• NDC 00472-0242-60 — Permethrin 5% creamAI (431 hospitals, 42,641–43,748 samples)
• NDC 00944-0493-02 — Flexbumin 25% albumin IV solutionAI (535 hospitals, 36,225–43,722 samples)
• NDC 72611-0722-25 — Ketorolac 30 mg/mL injectionAI (337 hospitals, 41,579–43,721 samples)
• NDC 50419-0346-15 — Iopromide 370 injection, 150 mL vialAI (62 hospitals, 43,576–43,711 samples)
• NDC 61314-0637-05 — Prednisolone acetate 1% eye dropsAI (1117 hospitals, 42,242–43,682 samples)
• NDC 00409-3793-01 — Ketorolac 15 mg/mL injectionAI (418 hospitals, 40,333–43,663 samples)
• NDC 00641-6028-01 — Fentanyl injection, 50 mcg per mLAI (334 hospitals, 34,820–43,604 samples)
• NDC 00944-2700-10 — Immune globulin (IgG) 10% injectionAI (346 hospitals, 43,439–43,583 samples)
• NDC 71266-5025-02 — Norepinephrine IV infusion in salineAI (84 hospitals, 42,446–43,580 samples)
• NDC 43598-0549-52 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (208 hospitals, 41,077–43,552 samples)
• NDC 55150-0226-10 — Rocuronium 10 mg/mL injectionAI (354 hospitals, 42,259–43,510 samples)
• NDC 24208-0315-10 — Polymyxin B and trimethoprim eye drops, 10 mL bottleAI (736 hospitals, 42,354–43,506 samples)
• NDC 08290-3064-24 — Heparin lock flush solutionAI (490 hospitals, 37,081–43,444 samples)
• NDC 67457-0422-00 — Dexamethasone sodium phosphate injection, 4 mg/mLAI (484 hospitals, 37,133–43,415 samples)
• NDC 13925-0515-01 — Pentamidine 300 mg injectionAI (150 hospitals, 42,008–43,412 samples)
• NDC 24208-0505-05 — Levobunolol 0.5% eye drops, 5 mL bottleAI (637 hospitals, 42,237–43,371 samples)
• NDC 24208-0910-19 — Erythromycin eye ointmentAI (1110 hospitals, 41,563–43,300 samples)
• NDC 71288-0700-05 — Rocuronium bromide injection, 50 mg per 5 mLAI (231 hospitals, 41,882–43,295 samples)